I-5-Bromo-2-Nitropyridine CAS 39856-50-3 Ukuhlanzeka >99.5% (HPLC) Isithombe Esifakiwe Sefekthri

I-5-Bromo-2-Nitropyridine CAS 39856-50-3 Ubumsulwa >99.5% (HPLC) Factory

Incazelo emfushane:

Igama Lekhemikhali: 5-Bromo-2-Nitropyridine

I-CAS: 39856-50-3

Ubumsulwa: >99.5% (HPLC)

Ukubukeka: Impushana Ephuzi Kancane noma Ensundu

Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

Iselula/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Thumela i-imeyili kithi

Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 5-Bromo-2-Nitropyridine (CAS: 39856-50-3) with high quality. We can provide COA, worldwide delivery, small and bulk quantities available. If you are interested in this product, please send detailed information includes CAS number, product name, quantity to us. Please contact: alvin@ruifuchem.com

Chemical Properties:

Igama Lekhemikhali	I-5-Bromo-2-Nitropyridine
Inombolo ye-CAS	39856-50-3
Inombolo yeCAT	I-RF-PI578
Isimo Sesitoko	Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula	I-C5H3BrN2O2
Isisindo samangqamuzana	203.00
Ibhrendi	I-Ruifu Chemical

Imininingwane:

Into	Imininingwane
Ukubukeka	Impushana Ephuzi Kancane noma Ensundu
Ukuhlanzeka / Indlela Yokuhlaziya	>99.5% (HPLC)
I-Melting Point	147.0 ~ 150.0℃
Umswakama (KF)	<0.50%
Ukungcola Okuphelele	<0.50%
I-Infrared Spectrum	Ivumelana Nesakhiwo
I-Proton NMR Spectrum	Ivumelana Nesakhiwo
Izinga Lokuhlola	I-Enterprise Standard
Ukusetshenziswa	Pharmaceutical Intermediates

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama

Izinzuzo:

I-FAQ:

Isicelo:

I-5-Bromo-2-Nitropyridine (i-CAS: 39856-50-3) i-organic intermediate, engatholakala nge-oxidation ye-2-Amino-5-Bromopyridine nge-hydrogen peroxide.I-5-Bromo-2-Nitropyridine kubikwe ukuthi ingasetshenziswa ukulungisa i-Parbosinib ne-Parboxib intermediate.